Additionally, it has been revealed that mutated p53 tended to bind with the AMP-activated protein kinase (AMPK) α subunit and then restrained its activation, resulting in increased lipid production and tumor growth in the head and neck cancer cells (53). This evidence concerns the gene TP53 and head and neck cancer.